Navidea Biopharmaceuticals Company
Navidea Biopharmaceuticals is a leader in precision medicine with immuno-targeted products designed to help identify the sites.
Headquarters:
United States
Last Funding Type:
Post-IPO Debt
Investors Number:
2
Acquisitions Number:
1
Employee Number:
11-50
Total Funding:
$92.5M
Founded Date:
1983-01-01
Technology:
Personalised Medicine
Estimated Revenue:
Less than $1M
Investor Type:
For Profit
Industry:
Genomic and Epigenominc Instabillity
Funding Status:
IPO